Clinical significance of gelatinases in septic arthritis of native and replaced knees

被引:11
作者
Chu, SC
Yang, SF
Lue, KH
Hsieh, YS
Lin, ZI
Lu, KH
机构
[1] Chung Shan Med Univ Hosp, Dept Orthopaed Surg, Taichung 402, Taiwan
[2] Chungtai Inst Hlth Sci & Technol, Dept Food Sci, Taichung, Taiwan
[3] Chung Shan Med Univ, Inst Biochem, Taichung, Taiwan
[4] Chung Shan Med Univ, Inst Med, Taichung, Taiwan
[5] Chung Shan Med Univ, Sch Med, Taichung, Taiwan
关键词
D O I
10.1097/01.blo.0000136832.94824.91
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
We hypothesized that more gelatinases appear in effusions of septic arthritis than aseptic arthritis. This study examined the laboratory variables of inflammation and the levels of gelatinase A and B (matrix metalloproteinases-2 and -9) in 75 effusions from the knees of 37 patients with inflammatory arthritis and compared them with effusions of septic and aseptic arthritis. Gelatin zymography revealed that the levels of the latent matrix metalloproteinase-9 were higher in 24 effusions of septic arthritis than in 51 effusions of aseptic arthritis. The latent matrix metalloproteinase-9 levels of septic arthritis also correlated with the neutrophil counts in effusions. Significantly more activated matrix metalloproteinases-2 and -9 appeared in effusions of septic arthritis in native and replaced knees than in effusions of aseptic arthritis. A high matrix metalloproteinase-9 level and the appearance of activated matrix metalloproteinases-2 and -9 may distinguish septic from aseptic arthritis, even in cases with a low neutrophil count in the replaced knee. Joint aspiration may not only reduce the bacteria counts, endotoxins, and proinflammatory cytokines, but also decrease the amount of matrix metalloproteinases in effusions that attack the extracellular matrix of native and artificial joints.
引用
收藏
页码:179 / 183
页数:5
相关论文
共 33 条
[1]
ARCHIBECK MJ, 2001, CLIN ORTHOP RELAT R, V392, P377
[2]
Matrix metalloproteinases 2 and 9 activity in bovine synovial fluids [J].
Arican, M ;
Coughlan, AR ;
Clegg, D ;
Carter, SD .
JOURNAL OF VETERINARY MEDICINE SERIES A-PHYSIOLOGY PATHOLOGY CLINICAL MEDICINE, 2000, 47 (08) :449-456
[3]
THE AMERICAN-RHEUMATISM-ASSOCIATION 1987 REVISED CRITERIA FOR THE CLASSIFICATION OF RHEUMATOID-ARTHRITIS [J].
ARNETT, FC ;
EDWORTHY, SM ;
BLOCH, DA ;
MCSHANE, DJ ;
FRIES, JF ;
COOPER, NS ;
HEALEY, LA ;
KAPLAN, SR ;
LIANG, MH ;
LUTHRA, HS ;
MEDSGER, TA ;
MITCHELL, DM ;
NEUSTADT, DH ;
PINALS, RS ;
SCHALLER, JG ;
SHARP, JT ;
WILDER, RL ;
HUNDER, GG .
ARTHRITIS AND RHEUMATISM, 1988, 31 (03) :315-324
[4]
Recurrence of gout after total knee arthroplasty [J].
Blyth, P ;
Pai, VS .
JOURNAL OF ARTHROPLASTY, 1999, 14 (03) :380-382
[5]
Effect of hemodialysis on the plasma level of type IV collagenases and their inhibitors [J].
Chou, FP ;
Chu, SC ;
Cheng, MC ;
Yang, SF ;
Cheung, WN ;
Chiou, HL ;
Hsieh, YS .
CLINICAL BIOCHEMISTRY, 2002, 35 (05) :383-388
[6]
The clinical significance of gelatinase B in gouty arthritis of the knee [J].
Chu, SC ;
Yang, SF ;
Lue, KH ;
Hsieh, YS ;
Hsiao, TY ;
Lu, KH .
CLINICA CHIMICA ACTA, 2004, 339 (1-2) :77-83
[7]
Characterisation of equine matrix metalloproteinase 2 and 9; and identification of the cellular sources of these enzymes in joints [J].
Clegg, PD ;
Burke, RM ;
Coughlan, AR ;
Riggs, CM ;
Carter, SD .
EQUINE VETERINARY JOURNAL, 1997, 29 (05) :335-342
[8]
Matrix metalloproteinases 2 and 9 in equine synovial fluids [J].
Clegg, PD ;
Coughlan, AR ;
Riggs, CM ;
Carter, SD .
EQUINE VETERINARY JOURNAL, 1997, 29 (05) :343-348
[9]
Matrix metalloproteinases 2 and 9 in canine rheumatoid arthritis [J].
Coughlan, AR ;
Robertson, DHL ;
Bennett, D ;
May, C ;
Beynon, RJ ;
Carter, SD .
VETERINARY RECORD, 1998, 143 (08) :219-223
[10]
Regulation of interleukin-8 expression by reduced oxygen pressure in human glioblastoma [J].
Desbaillets, I ;
Diserens, AC ;
de Tribolet, N ;
Hamou, MF ;
Van Meir, EG .
ONCOGENE, 1999, 18 (07) :1447-1456